KharyEdwardsMD
Endocrinology • Bristol, CTAdrenal Disease, Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine
Physician
Dr. Edwards is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
41 Brewster Rd
Bristol, CT 06010Phone+1 860-940-6300Fax+1 860-940-6745
Education & Training
St. George's University School of MedicineClass of 2015
Certifications & Licensure
CT State Medical License 2017 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 26 citationsClinical and Safety Outcomes With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study.Khary Edwards, Xilong Li, Ildiko Lingvay
The Journal of Clinical Endocrinology and Metabolism. 2023-03-10 - 1 citationsPatient-perceived benefits and risks of off-label use of SGLT2 inhibitors and GLP-1 receptor agonists in type 1 diabetes: a structured qualitative assessment.Khary Edwards, Aleksandra Uruska, Anna Duda-Sobczak, Dorota Zozulinska-Ziolkiewicz, Ildiko Lingvay
Therapeutic Advances in Endocrinology and Metabolism. 2023-01-01 - 14 citationsTelehealth utilization among multi-ethnic patients with obesity during the COVID-19 pandemic.Jaime P. Almandoz, Luyu Xie, Jeffrey N. Schellinger, M. Sunil Mathew, Khary Edwards
Journal of Telemedicine and Telecare. 2021-03-04
Press Mentions
Study Provides a Rare View of Real-World Use of off-Label Drugs Prescribed for Type 1 DiabetesFebruary 16th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
